Buspirone Hydrochloride Tablet
Product Images NDC 71610-975

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Buspirone Hydrochloride (NDC 71610-975). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (71610 0975 60)

Label (71610 0975 60)
Buspirone hydrochloride 15 mg tablet label showing a bottle containing 90 tablets. The label includes storage instructions to keep between 20-25°C and out of reach of children, manufacturer information for Bayer Pharmaceuticals, Inc. in Hauppauge, NY, and repackaging by Aphena Pharma in Cookeville, TN. The label indicates it is a prescription drug and provides an NDC of 71610-975-60.*
FDA Label Image

Aphena (Aphena)

FDA Label Image

Chemical-structure (Chemical Structure)

Chemical-structure (Chemical Structure)
Chemical structure diagram of Buspirone hydrochloride, showing the molecular formula C21H31N5O2·HCl and molecular weight of 421.96.*
FDA Label Image

Figure 1 (Fig 1)

Figure 1 (Fig 1)
An instructional diagram showing the dosage divisions of a buspirone hydrochloride 15 mg tablet. It illustrates how the tablet can be split into halves, thirds, and two-thirds, corresponding to 7.5 mg, 5 mg, and 10 mg doses, respectively, using portions of the scored tablet.*
FDA Label Image

Figure 2 (Figure2)

Figure 2 (Figure2)
An instructional illustration showing hands holding and breaking a tablet in half, demonstrating how to split the tablet properly.*
FDA Label Image

Figure 3 (Figure3)

Figure 3 (Figure3)
An illustration showing different scored segments of buspirone hydrochloride tablets to indicate partial doses. It displays a full 30 mg tablet and partial divisions marked as two-thirds (20 mg), one-half (15 mg), and one-third (10 mg) of a tablet, demonstrating how the tablet can be split to achieve these doses.*
FDA Label Image

Figure 4 (Figure4)

Figure 4 (Figure4)
An instructional illustration showing two hands using their fingers to break or split a tablet, likely demonstrating how to safely divide a tablet into smaller doses for oral use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.